查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
骨密度測定係統市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)
市場調查報告書
商品編碼
1190127

骨密度測定係統市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Bone Densitometer Systems Market - Growth, Trends, and Forecasts (2023- 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，骨密度測定係統市場預計將以 3.5% 的複合年增長率增長。

COVID-19 大流行對骨密度測定係統市場產生了重大影響。 COVID-19 疾病和治療對倖存患者的骨骼健康產生不利影響，影響了市場的增長速度。 根據國家醫學圖書館 2022 年 4 月發表的一篇論文，COVID-19 的急性後遺症可導致繼發性骨質疏鬆症。 為了幫助及早發現和治療骨質疏鬆症問題，我們正在廣泛調查隨訪中 COVID-19 住院倖存患者的骨骼健康狀況。 隨著COVID-19患者的增加，骨密度的早期檢測和骨檢查增加，增加了對骨密度儀的需求。

骨關節炎和維生素缺乏症患病率的上升、骨密度測定的日益普及以及技術進步是推動骨密度測定係統市場增長的主要因素。 例如，根據關節炎社區研究和評估單位 (ACREU) 發表的一篇文章，2021 年大約 15% 的 20 歲以上的加拿大人將患有骨關節炎。 此外，超過 400 萬加拿大人，即大約七分之一的成年人患有骨關節炎。 如此高的疾病負擔預計將增加對用於準確診斷的骨密度測量系統的需求，並最終推動市場增長。 Clilactic 發表的一項研究發現，到 2022 年 1 月，骨質疏鬆症每年將導致超過 890 萬例骨折，全球每三秒鐘就有一例骨質疏鬆性骨折發生。 據估計，骨質疏鬆症影響著全世界 2 億婦女。

此外，各種醫療保健提供商採用骨密度計也有助於市場增長。 例如，2021 年 6 月，Healthshare Group 旗下的倫敦 Riverside Clinic 採用 Fujifilm 的 DXA 解決方案進行骨質疏鬆症診斷社區試驗。

骨關節炎和維生素缺乏症的患病率上升、骨密度計的使用率增加以及技術進步等因素正在推動骨密度計系統市場的增長。 然而，與骨密度計相關的風險及其高成本可能會限制市場增長。

主要市場趨勢

雙能 X 射線吸收測定 (DEXA) 細分市場預計在預測期內實現高速增長

在軸向骨密度測定中，雙能 X 射線吸收測定法 (DEXA) 是評估體內骨密度的最廣泛使用的技術。 該設備用於中心和外周骨礦物質密度 (BMD) 掃描，由於其高精度、易於操作以及對成人和兒童安全而得到廣泛使用。 雙能 X 射線吸收測定法（DEXA 或 DXA）用於診斷骨質減少和骨質疏鬆症。 由於骨質疏鬆症的患病率很高，人們認為患病率的增加是由於能夠滿足臨床醫生的不同需求。

此外，持續的技術發展，例如數字檢測器和計算機輔助超聲波密度計的集成，展示了高舒適度、可操作性和縮短的測量時間。 例如，2022年2月，Echolight Medical與Aurora Spine Corporation簽訂了合作聯合營銷協議。 Aurora 使用 DEXA 技術開發和製造脊柱植入物，Echolight 使用非電離輻射進行骨骼健康評估業務。 此外，2022 年 1 月，貝克曼庫爾特在迪拜世界貿易中心舉辦的 2022 MEDLAB Middle East 上展出了已發布的工作流自動化系統 DxA 5000 Fit。 因此，所有這些技術進步、發布和合作戰略都有望促進目標市場的增長。

雙能 X 射線吸收測定法的採用率提高等因素預計將在預測期內推動市場的細分增長。

北美地區在預測期內將主導骨密度測量系統市場

由於各地區公司為提高研發能力和保持高標準的醫療保健而開展的各種合作，預計北美市場份額很大，從而推動了整個地區的需求。 美國的骨密度測定係統市場受到醫療保健系統中先進技術越來越多的使用以及該國慢性病負擔不斷增加的推動。 例如，根據美國癌症協會2022年的統計，2022年美國估計將有3910例骨關節癌新發病例，其中女性1750例，男性2160例。 癌症是骨質流失和骨折的主要因素，因為癌細胞直接影響身體的骨骼，而抗癌藥物會對骨細胞產生不利影響。 增加的癌症負擔也促進了該地區的市場增長，因為骨密度計系統有助於評估骨折風險。

此外，2021 年加拿大骨關節炎負擔報告指出，骨關節炎的患病率隨著年齡的增長而增加。 另據報導，超過一半（52%）的加拿大骨關節炎患者年齡在 65 歲以下。 同一份文件還報告說，超過 400 萬加拿大人，即大約七分之一的成年人患有骨關節炎。 因此，隨著慢性病的增多，醫療機構對準確診斷和高效及時的治療規劃的需求越來越大。 因此，該地區的研究目標市場預計在未來幾年將會增長。

此外，由於該地區老年人口的增加，市場有望擴大。 例如，加拿大統計局的 2021 年人口普查發現，65 歲及以上的人口大約有 7,021,430 人，其中男性 3,224,680 人，女性 3,796,750 人。 由於老年人最容易患上各種與年齡相關的骨骼疾病，因此醫療機構對骨密度測定係統的需求不斷增加，預計將推動市場增長。

因此，由於醫療保健系統中先進技術的使用增加和慢性病負擔增加等因素，預計北美地區的市場在預測期內將出現增長。

競爭格局

由於公司在全球和區域開展業務，骨密度測定係統市場規模不大。 競爭格局是GE Healthcare, Hologic, Beamed, DMS Imaging, Swiss Ray International, Singaoy Medical Devices, Eurotech Medical Systems SRL, Tribitron Healthcare, Scanflex Healthcare AB, Mednica, Osteosys, Cyber□□ Analysis等國際組織以及當地知名企業包括 Logic、MEDILINK、Osteometer Meditech、CompuMed、Echolight S.p.a 和 Eurotech Medical Systems SRL 等公司。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 骨質疏鬆症和維生素 D 缺乏症的發病率增加
    • 提高骨密度計的普及率
    • 骨密度測定領域的技術進展
  • 市場製約因素
    • 與骨密度計相關的風險
    • 骨密度計成本高
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按技術
    • 軸向骨密度計
      • 雙能 X 射線吸收測定法 (DEXA)
      • 定量計算機斷層掃描 (QCT)
    • 外周骨密度測定
      • 單能 X 射線吸收測定法 (SEXA)
      • 雙能 X 射線吸收測定法 (pDEXA)
      • 輻射吸收測量 (RA)
      • 定量超聲 (QUS)
      • 外周定量計算機斷層掃描 (pQCT)
  • 最終用戶
    • 醫院
    • 專科診所
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • GE Healthcare
    • Hologic Inc.
    • Beammed Ltd.
    • DMS Imaging
    • Swissray International, Inc.
    • MEDILINK
    • Osteometer MediTech
    • CompuMed, Inc.
    • Echolight S.p.a
    • Eurotec Medical Systems srl
    • Xingaoyi Medical Equipment Co. Ltd
    • Trivitron Healthcare
    • Scanflex Healthcare AB
    • Medonica Co. LTD
    • OsteoSys Corp

第7章 市場機會今後動向

簡介目錄
Product Code: 67159

The bone densitometer systems market is expected to register a CAGR of 3.5% over the forecast period.

The COVID-19 pandemic impacted the bone densitometer systems market significantly. The COVID-19 illness and treatment adversely affected the bone health of surviving patients, affecting the market's growth pace. According to an article published by the National Library of Medicine in April 2022, post-acute sequela of COVID-19 can cause secondary osteoporosis. To help with the early detection and treatment of osteoporosis problems, the bone health status of patients who survived COVID-19 hospitalization was extensively examined at subsequent visits. With the increased number of COVID-19 patients, the early detection of bone density and bone examination increased, leading to increased demand for bone densitometers.

The rising prevalence of osteoarthritis and vitamin deficiencies, increased adoption of bone densitometers, and technological advancements are key factors fueling the bone densitometer systems market growth. For instance, according to an article published by the Arthritis Community Research and Evaluation Unit (ACREU), in 2021 around 15% of Canadians aged 20 years and above had osteoarthritis. The report further stated that more than 4 million Canadians, or about one in every seven adults, have osteoarthritis. The high burden of such disorders is expected to boost the demand for bone densitometer systems for accurate diagnosis, ultimately driving market growth. According to a study published by Climacteric, in January 2022, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds, globally. It is estimated that osteoporosis affects 200 million women worldwide.

Additionally, the adoption of bone densitometers by various healthcare providers also contributes to the growth of the market. For instance, in June 2021, the Riverside Clinic in London, part of the Healthshare Group, chose Fujifilm's DXA Solution for the community trial to diagnose osteoporosis.

Factors such as rising prevalence of osteoarthritis and vitamin deficiencies, increased adoption of bone densitometers and technological advancements are driving the market growth for the bone densitometer systems market. However, risks associated with bone densitometers and the high cost of it may restrain the market growth.

Key Market Trends

Dual Energy X-ray Absorptiometry (DEXA) Segment is Expected to Witness High Growth Over the Forecast Period

In axial bone densitometry, dual-energy X-ray absorptiometry (DEXA) is the most widely used technique for assessing bone density in the body. This device is used for both central and peripheral bone mineral density (BMD) scans and is widely used due to its high precision, easy handling, and safety of usage for adults and children. Dual-energy x-ray absorptiometry (DEXA or DXA) is used to aid in diagnosing osteopenia and osteoporosis. The increasing adoption rate can be attributed to the fulfillment of different requirements of clinicians by dual-energy x-ray absorptiometry, as there is a high prevalence of osteoporosis in the population.

Furthermore, consistent technological developments, such as integrating digital detectors and computer-assisted and ultrasonic densitometers, have been proven to have high comfort, ease of operation, and reduced measuring time. For instance, in February 2022, Echolight Medical and Aurora Spine Corporation engaged in a cooperative co-marketing agreement. Aurora is engaged in developing and manufacturing DEXA Technology-based Spinal Implants, while Echolight is in the business of non-ionizing radiation bone health assessment. Additionally, in January 2022, Beckman Coulter displayed its launched DxA 5000 Fit workflow-automation system at the 2022 edition of MEDLAB Middle East held at the Dubai World Trade Centre. Hence, all these technological advancements, launches, and partnership strategies are expected to lead to the target market's growth.

Factors such as the increasing adoption rate of Dual-energy x-ray absorptiometry are expected to drive segmental growth in the market during the forecast period.

North America Region is Dominating the Bone Densitometer Systems Market Over the Forecast Period

North America has accounted for a large market share due to the various collaborative efforts undertaken by various regional companies to improve their R&D capabilities and maintain high medical standards, which are expected to propel the demand across this region. The market for bone densitometer systems in United States is being driven by the increasing use of advanced technology in healthcare systems and the rising burden of chronic diseases in the country. For instance, according to the American Cancer Society's 2022 statistics, it is estimated that in United States, there are a total of 3,910 new cases of bone and joint cancer, out of which 1,750 are females and 2,160 are males in 2022. Cancer is a significant contributor to bone loss and fractures since cancer cells directly impact the body's skeleton and cancer-specific medicines have adverse effects on bone cells, since the bone densitometer system helps in assessing the risk of fractures, the rising burden of cancer also contributes to the growth of the market in the region.

Additionally, the Burden of Osteoarthritis in Canada, 2021 report, stated that the prevalence of osteoarthritis rises with age. It also reported that more than half (52%) of Canadians who have osteoarthritis are younger than 65. The same source also reported that more than 4 million Canadians, or about 1 in every 7 adults, have osteoarthritis. Therefore, the increased prevalence of chronic diseases increases the demand for accurate diagnosis and a treatment plan that is both efficient and timely from healthcare providers. As a result, the studied market in the region is expected to grow over the coming years.

Furthermore, the market is predicted to grow due to the growing elderly population in the region. For instance, as per Statistics Canada's 2021 census, there were around 7,021,430 people aged 65 years or above, out of which 3,224,680 were males and 3,796,750 were females. As the aged population is most vulnerable to various age-related bone diseases, the demand for bone densitometer systems at healthcare facilities is anticipated to increase, propelling market growth.

Thus, owing to the factors such as increasing use of advanced technology in healthcare systems and the rising burden of chronic diseases, the studied market in the North American region is expected to project growth over the forecast period.

Competitive Landscape

The bone densitometer systems market is moderate due to the presence of companies operating globally and regionally. The competitive landscape includes an analysis of international as well as local companies well known including GE Healthcare, Hologic Inc., Beammed Ltd., DMS Imaging, Swissray International, Inc., Xingaoyi Medical Equipment Co. Ltd., Eurotec Medical Systems Srl, Trivitron Healthcare, Scanflex Healthcare AB, Medonica Co. Ltd., OsteoSys Corp, CyberLogic, Inc., MEDILINK, Osteometer MediTech, CompuMed, Inc., Echolight S.p.a, and Eurotec Medical Systems SRL., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Surge in Incidence of Osteoporosis and Vitamin D Deficiency
    • 4.2.2 Increase in Adoption of Bone Densitometers
    • 4.2.3 Technological Advancements in the Field of Bone Densitometry
  • 4.3 Market Restraints
    • 4.3.1 Risks Associated with Bone Densitometers
    • 4.3.2 High Cost of Bone Densitometers
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technology
    • 5.1.1 Axial Bone Densitometry
      • 5.1.1.1 Dual energy X-ray absorptiometry (DEXA)
      • 5.1.1.2 Quantitative computed tomography (QCT)
    • 5.1.2 Peripheral Bone Densitometry
      • 5.1.2.1 Single Energy X-Ray Absorptiometry (SEXA)
      • 5.1.2.2 Dual Energy X-Ray Absorptiometry (pDEXA)
      • 5.1.2.3 Radiographic Absorptiometry (RA)
      • 5.1.2.4 Quantitative Ultrasound (QUS)
      • 5.1.2.5 Peripheral Quantitative Computed Tomography (pQCT)
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Specialty Clinics
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 GE Healthcare
    • 6.1.2 Hologic Inc.
    • 6.1.3 Beammed Ltd.
    • 6.1.4 DMS Imaging
    • 6.1.5 Swissray International, Inc.
    • 6.1.6 MEDILINK
    • 6.1.7 Osteometer MediTech
    • 6.1.8 CompuMed, Inc.
    • 6.1.9 Echolight S.p.a
    • 6.1.10 Eurotec Medical Systems srl
    • 6.1.11 Xingaoyi Medical Equipment Co. Ltd
    • 6.1.12 Trivitron Healthcare
    • 6.1.13 Scanflex Healthcare AB
    • 6.1.14 Medonica Co. LTD
    • 6.1.15 OsteoSys Corp

7 MARKET OPPORTUNITIES AND FUTURE TRENDS